NanoRay Biotech is invited to attend 10th International Symposium on the Physical, Molecular, Cellular and Medical Aspects of Auger Electron Processes, which will be held in Montpellier (France) on Sep. 6 – 8, 2023. It is also the centenary for the first article describing “Auger effect”, published by Pierre Auger.
Symposium information：Auger Symposium – September 6-8, 2023 (auger-symposium.com)
NanoRay Biotech will have an oral presentation to introduce their researches on Auger Molecular Therapy along with its clinical application. Auger effect has been expected to be applied in cancer therapy for decades, but numerous hurdles still exist. For example, the monochromatic photons necessary for induction of Auger effect can be only produced by synchrotron radiation currently, which cannot be translated to clinical study. The special design of NanoRay Biotech’s transmission-target X-ray module can generate characteristic photons similar to synchrotron radiation, efficiently induce Auger effect in cancer DNA when combined with specific heavy-atom drug.
The IND for Auger Molecular Therapy has been approved by US FDA, and a phase 1 clinical trial will start in Taipei Medical University Hospital by 2023.